Silence Therapeutics Insider Adds 25K ADS, Ups Stake to 11.78M Shares
Rhea-AI Filing Summary
Silence Therapeutics plc (SLN) – Form 4 insider buying
10% owner Richard Ian Griffiths, via Cream Capital Ltd., disclosed open-market purchases on 21-22 Jul 2025 of 25,345 American Depositary Shares (ADS) at $6.04 and $6.09. Each ADS converts into three ordinary shares, increasing his indirect holding by roughly 76,035 ordinary shares.
Post-trade, Griffiths’ beneficial position totals ≈11.78 million ADS-equivalent shares. No sales were reported. Continued accumulation by a 10% holder generally signals confidence in the company’s outlook and may support sentiment toward SLN shares.
Positive
- 10% owner increased position by 25,345 ADS (~76k ordinary shares), demonstrating confidence.
- No shares were sold, eliminating mixed signals and underscoring a net accumulation stance.
Negative
- None.
Insights
TL;DR: Major shareholder adds 25k ADS, modest dollar outlay but positive signal of confidence.
The purchases expand Griffiths’ stake by ~0.2%, costing about US$154k. While immaterial to ownership concentration, insider buying by a long-term 10% holder often reassures investors about near-term prospects and valuation (SLN recently traded near 52-week lows). No derivative complexity or sales dilute the signal. Impact is supportive rather than transformative but leans positive.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Purchase | American Depositary Shares | 2,910 | $0.00 | -- |
| Purchase | American Depositary Shares | 22,435 | $0.00 | -- |
Footnotes (1)
- Each American Depositary Share ("ADS") is immediately convertible into three ordinary shares for no consideration and has no expiration date. The securities are held by Cream Capital Limited ("Cream"). Mr. Griffiths is a director and the controlling shareholder of Cream. Mr. Griffiths disclaims beneficial ownership of these securities except to the extent of his proportionate pecuniary interest therein.
